1. Home
  2. THTX vs VATE Comparison

THTX vs VATE Comparison

Compare THTX & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • VATE
  • Stock Information
  • Founded
  • THTX 1993
  • VATE 1994
  • Country
  • THTX Canada
  • VATE United States
  • Employees
  • THTX N/A
  • VATE N/A
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • VATE Metal Fabrications
  • Sector
  • THTX Health Care
  • VATE Industrials
  • Exchange
  • THTX Nasdaq
  • VATE Nasdaq
  • Market Cap
  • THTX 118.2M
  • VATE 98.2M
  • IPO Year
  • THTX N/A
  • VATE 1996
  • Fundamental
  • Price
  • THTX $2.65
  • VATE $5.78
  • Analyst Decision
  • THTX Hold
  • VATE
  • Analyst Count
  • THTX 1
  • VATE 0
  • Target Price
  • THTX N/A
  • VATE N/A
  • AVG Volume (30 Days)
  • THTX 212.4K
  • VATE 45.1K
  • Earning Date
  • THTX 07-09-2025
  • VATE 05-06-2025
  • Dividend Yield
  • THTX N/A
  • VATE N/A
  • EPS Growth
  • THTX N/A
  • VATE N/A
  • EPS
  • THTX N/A
  • VATE N/A
  • Revenue
  • THTX $88,666,000.00
  • VATE $1,066,100,000.00
  • Revenue This Year
  • THTX N/A
  • VATE N/A
  • Revenue Next Year
  • THTX $15.13
  • VATE N/A
  • P/E Ratio
  • THTX N/A
  • VATE N/A
  • Revenue Growth
  • THTX 13.52
  • VATE N/A
  • 52 Week Low
  • THTX $1.12
  • VATE $3.25
  • 52 Week High
  • THTX $3.13
  • VATE $13.79
  • Technical
  • Relative Strength Index (RSI)
  • THTX 57.42
  • VATE 44.13
  • Support Level
  • THTX $2.54
  • VATE $5.63
  • Resistance Level
  • THTX $2.68
  • VATE $8.28
  • Average True Range (ATR)
  • THTX 0.11
  • VATE 0.70
  • MACD
  • THTX -0.03
  • VATE 0.01
  • Stochastic Oscillator
  • THTX 85.00
  • VATE 8.76

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: